Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-08-16
2009-02-03
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S305400
Reexamination Certificate
active
07485658
ABSTRACT:
Compounds represented by Formula (I):or a pharmaceutically acceptable salt or N-oxide thereof, are useful in the treatment of cancer.
REFERENCES:
patent: 6218388 (2001-04-01), Boschelli
patent: 6348032 (2002-02-01), Sperl
patent: 7282518 (2007-10-01), Sircar
patent: 2005/0187390 (2005-08-01), Schmitz et al.
patent: 2007/0202133 (2007-08-01), Sircar
International Search Report in PCT/US2004/026481.
International Preliminary Report on Patentability in PCT/US2004/026481.
Written Opinion of the International Searching Authority in PCT/US2004/026481.
Bolger Joshua
Castelhano Arlindo L.
Crew Andrew Phillip
Laufer Radoslaw
Li An-Hu
OSI Pharmaceuticals, Inc.
Saeed Kamal A
LandOfFree
N-substituted pyrazolyl-amidyl-benzimidazolyl c-Kit inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-substituted pyrazolyl-amidyl-benzimidazolyl c-Kit inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-substituted pyrazolyl-amidyl-benzimidazolyl c-Kit inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4108520